Natixis Advisors, L.P. United Therapeutics Corp Transaction History
Natixis Advisors, L.P.
- $63 Billion
- Q2 2025
A detailed history of Natixis Advisors, L.P. transactions in United Therapeutics Corp stock. As of the latest transaction made, Natixis Advisors, L.P. holds 12,248 shares of UTHR stock, worth $4.94 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,248
Previous 118,582
89.67%
Holding current value
$4.94 Million
Previous $36.6 Million
90.37%
% of portfolio
0.01%
Previous 0.07%
Shares
10 transactions
Others Institutions Holding UTHR
# of Institutions
745Shares Held
44.1MCall Options Held
340KPut Options Held
318K-
Black Rock Inc. New York, NY5.47MShares$2.21 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.45MShares$1.8 Billion0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.37MShares$957 Million12.42% of portfolio
-
State Street Corp Boston, MA2.17MShares$875 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.12MShares$855 Million0.86% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $18.4B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...